Drug Development Direction
In response to unmet medical needs, Cali Biosciences specifically develops perioperative anesthesia, analgesia and anti-inflammatory drugs, and is committed to building a product pipeline that focuses on market segments and has global competitive advantages.
Cali Biosciences has multiple patented drug delivery technology platforms. All of our patented technology platforms have significant advantages in the field of new drug R&D, especially in the field of formulation development, mainly in solving the problem of poor solubility of drug APIs, enhancing the effectiveness of drugs and slow-release capabilities.
Cali Biosciences's drug R&D center focuses on the research of complex formulations. We have a R&D center in Shenzhen and a clinical development center in Shanghai.